Hpv vaccine to prevent cancer of the cervix of uterus
International Journal of Development Research
Hpv vaccine to prevent cancer of the cervix of uterus
Received 11th February, 2020; Received in revised form 17th March, 2020; Accepted 20th April, 2020; Published online 30th May, 2020
Copyright © 2020, Samara Letícia Mendonça Pereira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Objectives: search in the literature publications of the last ten years aiming to discuss the importance of the HPV vaccine for the prevention of cervical cancer. Methods: integrative review, with searches in the databases of LILACS, BVS, Scielo, Bireme. Results: We selected 81 publications, where 08 were read and adapted to the inclusion criteria. The diversity of studies emphasize the importance of the HPV vaccine in the age group from 9 to 13 years. There are factors that interfere in the adhesion to the vaccine, identifying the disparity between the official public communication and the media, resulting in doubts and fears. Conclusion: The nurse should offer quality care in Primary Care, producing satisfactory information and educational actions regarding the HPV vaccine. There is a need to propose effective public policies favoring health education for better adherence and results.
